Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Belite Bio, Inc (BLTE), most recent 12 months reported: net loss $77.61M, free cash flow -$37.06M. Latest balance sheet on file: liquid cash $492.42M. From SEC filings. More on Belite Bio, Inc: Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: BRIACELL THERAPEUTICS CORP. · Biohaven Ltd. · BioVie Inc. · BIOXYTRAN, INC. · Biomea Fusion, Inc. · BENITEC BIOPHARMA INC. · BOUNDLESS BIO, INC. · BeyondSpring Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.